Market Cap
$121.36 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
![]() |
$622.07 B |
![]() |
$115.11 B |
![]() |
$95.75 B |
Marinomed Biotech AG | $75.67 B |
![]() |
$44.44 B |
Company | Market Cap (USD) |
---|---|
![]() |
$808.65 B |
![]() |
$622.07 B |
![]() |
$450.89 B |
![]() |
$350.63 B |
![]() |
$318.75 B |
Top 1-year algo backtest: +207.50%
$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.
Boost your investing & swing trading... Now!
Try Disfold DeepFinance FREE
Vertex Pharmaceuticals Incorporated is a pharmaceuticals and biotherapeutics company. It notably produces drugs and genetic therapies for cystic fibrosis and other skin conditions, such as pain, sickle cell disease, beta-thalassemia, hormonal deficiencies, kidney diseases, Duchenne muscular dystrophy, and diabetes.
Vertex Pharmaceuticals Incorporated has the following listings and related stock indices.
Stock: NASDAQ: VRTX
Stock: FSX: VX1
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.